These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 18469690)

  • 1. Vestibular-evoked myogenic potential (VEMP) to evaluate cervical myelopathy in human T-cell lymphotropic virus type I infection.
    Felipe L; Gonçalves DU; Santos MA; Proietti FA; Ribas JG; Carneiro-Proietti AB; Lambertucci JR
    Spine (Phila Pa 1976); 2008 May; 33(11):1180-4. PubMed ID: 18469690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the vestibular evoked myogenic potential (VEMP) to identify subclinical neurological alterations in different phases of human T-lymphotropic virus type 1 infection.
    Felipe L; Kingma H; Lambertucci JR; Carneiro-Proietti AB; Gonçalves DU
    Spine J; 2013 Apr; 13(4):397-401. PubMed ID: 23267739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular vestibular evoked myogenic potential (VEMP) reveals mesencephalic HTLV-1-associated neurological disease.
    Silva TR; Labanca L; Caporali JFM; Santos MAR; Resende LM; Scoralick Dias RT; Utsch Gonçalves D
    PLoS One; 2019; 14(12):e0217327. PubMed ID: 31881022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vestibular-evoked myogenic potential triggered by galvanic vestibular stimulation may reveal subclinical alterations in human T-cell lymphotropic virus type 1-associated myelopathy.
    Labanca L; de Morais Caporali JF; da Silva Carvalho SA; Lambertucci JR; Carneiro Proietti ABF; Romanelli LCF; Avan P; Giraudet F; Souza BO; Florentino KR; Utsch Gonçalves D
    PLoS One; 2018; 13(7):e0200536. PubMed ID: 30001400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological analysis shows dizziness as the first symptom in human T cell lymphotropic virus type-associated myelopathy/tropical spastic paraparesis.
    Labanca L; Starling AL; de Sousa-Pereira SR; Romanelli LC; de Freitas Carneiro-Proietti AB; Carvalho LN; Fernandes DR; Utsch Gonçalves D
    AIDS Res Hum Retroviruses; 2015 Jun; 31(6):649-54. PubMed ID: 25760424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
    J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurological symptoms and disability in HTLV-1 associated myelopathy].
    Carod-Artal FJ; Mesquita HM; Ribeiro Lda S
    Neurologia; 2008 Mar; 23(2):78-84. PubMed ID: 18322825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections].
    Domínguez MC; Torres M; Tamayo O; Criollo W; Quintana M; Sánchez A; García F
    Biomedica; 2008 Dec; 28(4):510-22. PubMed ID: 19462556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
    Pinheiro SR; Martins-Filho OA; Ribas JG; Catalan-Soares BC; Proietti FA; Namen-Lopes S; Brito-Melo GE; Carneiro-Proietti AB;
    Am J Ophthalmol; 2006 Nov; 142(5):811-15. PubMed ID: 16989761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.
    Lenzi ME; Cuzzi-Maya T; Oliveira AL; Andrada-Serpa MJ; Araújo AQ
    Clin Infect Dis; 2003 Feb; 36(4):507-13. PubMed ID: 12567310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing.
    Caporali JFM; Labanca L; Florentino KR; Souza BO; Utsch Gonçalves D
    PLoS One; 2018; 13(9):e0204449. PubMed ID: 30261002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
    Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
    J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.
    Vasconcelos BHB; Callegari B; Costa KHA; Barroso TGCP; Sousa RCM; Saunier G; Xavier MB; Souza GS
    Sci Rep; 2019 Aug; 9(1):11456. PubMed ID: 31391511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.